Dallas-Based Corganics Receives Series A Funding to Accelerate Delivery of Clinical Cannabinoid Products to Healthcare Providers

by | Nov 30, 2021
Corganics, formerly MD Farma, aims to bring a higher quality, more transparent product portfolio to the CBD market. The investment from Dallas-based Altacrest Capital is meant to propel the team into its next growth phase, fulfilling the mission to "deliver effective clinical cannabinoid products that healthcare professionals and their patients can trust."
stem cells
DFW Research Roundup: Cannabis, Earth-like Planets, and Stem Cells
by | Aug 25, 2017
Researchers across North Texas are making discoveries and breakthroughs in their laboratories.